Skip to main content

Health House International Health Care

$0.005 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
11 October 2024 at 4:08am
Register to track HHI and receive email alerts.

Health House International Limited distributes medicinal cannabis products in Australasia, the United Kingdom, and Europe. It supplies a range of pharmaceutical products to pharmacies, hospitals, government departments, ambulance workers, and other wholesalers. The company was formerly known as Health House Holdings Limited and changed its name to Health House International Limited in March 2021. Health House International Limited was incorporated in 2011 and is based in Perth, Australia, As on May 5, 2023 Health House International Limited operates as a subsidiary of Creso Pharma Limited.

Expand Company Description

Market Cap (18-May)

$891,124 (0th)

Close (19-May)

$0.005

Volume (19-May)

0

Shortsold (31-May)

84,000 (0.14%) (423rd)

52w High

$0.000

52w Low

$0.000

P/E

-

EPS

-0.03
Subject
StockBot
HHI Ann: Removal from Official List

StockBot
HHI Ann: Application for quotation of securities - HHI

StockBot
HHI Ann: Application for quotation of securities - HHI

StockBot
HHI Ann: Proposed issue of securities - HHI

StockBot
HHI Ann: Suspension from Quotation

StockBot
HHI Ann: Court approves Scheme and Scheme becomes effective

StockBot
HHI Ann: Second Court Hearing Update

StockBot
HHI Ann: Results of Scheme Meeting

StockBot
HHI Ann: Results of Annual General Meeting

StockBot
HHI Ann: Scheme consideration update

StockBot
HHI Ann: Scheme consideration update

StockBot
HHI Ann: Application for quotation of securities - HHI

StockBot
HHI Ann: Meeting address and Scheme consideration update

StockBot
HHI Ann: Appendix 4C Cash Flow Report - amended

StockBot
HHI Ann: Appendix 4C Cash Flow Report

StockBot
HHI Ann: March 2023 Quarterly Report

StockBot
HHI Ann: Application for quotation of securities - HHI

StockBot
HHI Ann: Scheme consideration update

StockBot
HHI Ann: Release from Escrow

StockBot
HHI Ann: Correction to ASX Announcement - Scheme consideration update

StockBot
HHI Ann: Scheme consideration update

StockBot
HHI Ann: Release from Escrow

StockBot
HHI Ann: Scheme consideration update

StockBot
HHI Ann: Letter to Shareholders, AGM NOM & Proxy Form

StockBot
HHI Ann: Dispatch of scheme booklet - scheme of arrangement with CPH

StockBot
HHI Ann: Scheme booklet registered by ASIC

StockBot
HHI Ann: Results of First Court Hearing

StockBot
HHI Ann: Reinstatement to Quotation

StockBot
HHI Ann: Appendix 4D & FY23 Interim Financial Report

StockBot
HHI Ann: Suspension from Quotation

StockBot
HHI Ann: Appendix 4C Cash Flow Report

StockBot
HHI Ann: December 2022 Quarterly Report

StockBot
HHI Ann: ZLD: Receipt of Creso Shares and Settlement of HHI loan

StockBot
HHI Ann: Reinstatement to Quotation

StockBot
HHI Ann: Appendix 4G

StockBot
HHI Ann: Annual Report to shareholders

StockBot
HHI Ann: Changes in Senior Management Team

StockBot
HHI Ann: Appendix 4C Cash Flow Report

StockBot
HHI Ann: September 2022 Quarterly Report

StockBot
HHI Ann: CPH: HHI Update & Product Registration in South Korea

StockBot
HHI Ann: CPH:Scheme Implementation Deed signed to acq Health House

StockBot
HHI Ann: ZLD: Partial Receipt and variation of Health House loan

StockBot
HHI Ann: Scheme implementation deed executed

StockBot
HHI Ann: Final Director's Interest Notice

StockBot
HHI Ann: HHI completes CanPharma sale and Board changes

StockBot
HHI Ann: Health House to sell CanPharma

StockBot
HHI Ann: AGM Date and Closing Date for Director Nominations

StockBot
HHI Ann: Suspension from Official Quotation

StockBot
HHI Ann: Reinstatement to Official Quotation

StockBot
HHI Ann: Suspension Lifted

Register to track HHI and receive email alerts.